Biomaterial-based drug delivery systems for the controlled release of neurotrophic factors

Biomedical Materials (Bristol)

Volumn 8, Issue 2, 2013, Pages

  Mohtaram, Nima Khadem ^a   Montgomery, Amy ^a   Willerth, Stephanie M ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MATERIALS; CELL CULTURE; HYDROGELS; NEUROLOGY; TISSUE ENGINEERING;

BRAIN-DERIVED NEUROTROPHIC FACTORS; DRUG DELIVERY SYSTEM; ELECTROSPUN NANOFIBERS; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEURAL TISSUE ENGINEERING; NEUROLOGICAL DISEASE; NEUROLOGICAL DISORDERS; NEUROTROPHIC FACTORS;

DRUG DELIVERY;

BRAIN DERIVED NEUROTROPHIC FACTOR; ELECTROSPUN NANOFIBER; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MICROSPHERE; NANOFIBER; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; UNCLASSIFIED DRUG;

CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; HYDROGEL; NEUROLOGIC DISEASE; REVIEW;

EID: 84875683543     PISSN: 17486041     EISSN: 1748605X     Source Type: Journal    
DOI: 10.1088/1748-6041/8/2/022001     Document Type: Review

References (103)

1. Kerkhoff H and Jennekens F G I 1993 Peripheral-nerve lesions - the neuropharmacological outlook Clin. Neurol. Neurosurg. 95 S103-8
2. Moore A M et al 2010 Controlled delivery of glial cell line-derived neurotrophic factor enhances motor nerve regeneration J. Hand Surg. Am. 35 2008-17
3. Shimoke K and Chiba H 2001 Nerve growth factor prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutical application for Parkinson's disease J. Neurosci. Res. 63 402-9 (Pubitemid 32183789)
4. Stroh M, Zipfel W R, Williams R M, Webb W W and Saltzman W M 2003 Diffusion of nerve growth factor in rat striatum as determined by multiphoton microscopy Biophys. J. 85 581-8 (Pubitemid 36753660)
5. Grondin R and Gash D M 1998 Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson's disease J. Neurol. 245 P35-42
6. Willerth S M and Sakiyama-Elbert S E 2007 Approaches to neural tissue engineering using scaffolds for drug delivery Adv. Drug Deliv. Rev. 59 325-38 (Pubitemid 46879972)
7. Hosseinkhani H and Hosseinkhani M 2009 Biodegradable polymer-metal complexes for gene and drug delivery Curr. Drug Saf. 4 79-83
8. Hosseinkhani H 2006 DNA nanoparticles for gene delivery to cells and tissue Int. J. Nanotechnol. 3 416-61 (Pubitemid 46003822)
9. Saltzman W M 2001 Engineering Principles for Drug Therapy (New York: Oxford University Press)
10. Mahoney M J and Saltzman W M 1996 Controlled release of proteins to tissue transplants for the treatment of neurodegenerative disorders J. Pharm. Sci. 85 1276-81 (Pubitemid 27014179)
11. Cao X D and Shoichet M S 1999 Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders Biomaterials 20 329-39 (Pubitemid 29054695)
12. Chen F M, An Y, Zhang R and Zhang M 2011 New insights into and novel applications of release technology for periodontal reconstructive therapies J. Control. Release 149 92-110
13. Anand P 2004 Neurotrophic factors and their receptors in human sensory neuropathies Prog. Brain Res. 146 477-92 (Pubitemid 37541400)
14. Bensadoun J-C, Pereira de Almeida L, Fine E G, Tseng J L, Déglon N and Aebischer P 2003 Comparative study of GDNF delivery systems for the CNS: polymer rods, encapsulated cells, and lentiviral vectors J. Control. Release 87 107-15 (Pubitemid 36255448)
15. Subramanian A, Krishnan U M and Sethuraman S 2009 Development of biomaterial scaffold for nerve tissue engineering: biomaterial mediated neural regeneration J. Biomed. Sci. 16 108
16. Tatard V M, Menei P, Benoit J P and Montero-Menei C N 2005 Combining polymeric devices and stem cells for the treatment of neurological disorders: a promising therapeutic approach Curr. Drug Targets 6 81-96 (Pubitemid 40394326)
17. Thompson B C et al 2010 Conducting polymers, dual neurotrophins and pulsed electrical stimulation - dramatic effects on neurite outgrowth J. Control. Release 141 161-7
18. Uebersax L, Mattotti M, Papaloizos M, Merkle H P, Gander B and Meinel L 2007 Silk fibroin matrices for the controlled release of nerve growth factor (NGF) Biomaterials 28 4449-60 (Pubitemid 47225114)
19. Zanin M P, Pettingill L N, Harvey A R, Emerich D F, Thanos C G and Shepherd R K 2012 The development of encapsulated cell technologies as therapies for neurological and sensory diseases J. Control. Release 160 3-13
20. Zhang S and Uludag H 2009 Nanoparticulate systems for growth factor delivery Pharm. Res. 26 1561-80
21. Madduri S and Gander B 2012 Growth factor delivery systems and repair strategies for damaged peripheral nerves J. Control. Release 161 274-82
22. Powell E M, Sobarzo M R and Saltzman W M 1990 Controlled release of nerve growth-factor from a polymeric implant Brain Res. 515 309-11 (Pubitemid 20176131)
23. Baldwin S P and Saltzman W M 1998 Materials for protein delivery in tissue engineering Adv. Drug Deliv. Rev. 33 71-86 (Pubitemid 28403537)
24. Biondi M, Ungaro F, Quaglia F and Netti P A 2008 Controlled drug delivery in tissue engineering Adv. Drug Deliv. Rev. 60 229-42 (Pubitemid 350236401)
25. Davis H E and Leach J K 2010 Designing bioactive delivery systems for tissue regeneration Ann. Biomed. Eng. 39 1-13
26. Thompson B C et al 2006 Optimising the incorporation and release of a neurotrophic factor using conducting polypyrrole J. Control. Release 116 285-94 (Pubitemid 44827404)
27. Tessmar J K and Gopferich A M 2007 Matrices and scaffolds for protein delivery in tissue engineering Adv. Drug. Deliv. Rev. 59 274-91 (Pubitemid 46879975)
28. Agterberg M J H, Versnel H, van Dijk L M, de Groot J C M J and Klis S F L 2009 Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs J. Assoc. Res. Otolaryngol. 10 355-67
29. Yoshimura N et al 2006 Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats J. Neurosci. 26 10847-55
30. Wang N X and von Recum H A 2011 Affinity-based drug delivery Macromol. Biosci. 11 321-32
31. Yang W W and Pierstorff E 2012 Reservoir-based polymer drug delivery systems J. Lab. Autom. 17 50-8
32. Johnson P J, Parker S R and Sakiyama-Elbert S E 2009 Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury Biotechnol. Bioeng. 104 1207-14
33. Johnson P J, Tatara A, Shiu A and Sakiyama-Elbert S E 2010 Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI Cell Transplant. 19 89-101
34. Maxwell D J, Hicks B C, Parsons S and Sakiyama-Elbert S E 2005 Development of rationally designed affinity-based drug delivery systems Acta Biomater. 1 101-13 (Pubitemid 43348812)
35. Sakiyama-Elbert S E and Hubbell J A 2000 Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix J. Control. Release 69 149-58
36. Taylor S J, McDonald J W 3rd and Sakiyama-Elbert S E 2004 Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury J. Control. Release 98 281-94 (Pubitemid 38950737)
37. Taylor S J and Sakiyama-Elbert S E 2006 Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model J. Control. Release 116 204-10 (Pubitemid 44854282)
38. Willerth S M, Johnson P J, Maxwell D J, Parsons S R, Doukas M E and Sakiyama-Elbert S E 2007 Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices J. Biomed. Mater. Res. A 80 13-23 (Pubitemid 44913329)
39. Willerth S M, Rader A and Sakiyama-Elbert S E 2008 The effect of controlled growth factor delivery on embryonic stem cell differentiation inside fibrin scaffolds Stem Cell Res. 1 205-18
40. Wood M D et al 2009 Affinity-based release of glial-derived neurotrophic factor from fibrin matrices enhances sciatic nerve regeneration Acta Biomater. 5 959-68
41. Edelman E R, Mathiowitz E, Langer R and Klagsbrun M 1991 Controlled and modulated release of basic fibroblast growth-factor Biomaterials 12 619-26
42. Fu A, Thatiparti T, Saidel G and Recum H 2011 Experimental studies and modeling of drug release from a tunable affinity-based drug delivery platform Ann. Biomed. Eng. 39 2466-75
43. Wood M D, Borschel G H and Sakiyama-Elbert S E 2009 Controlled release of glial-derived neurotrophic factor from fibrin matrices containing an affinity-based delivery system J. Biomed. Mater. Res. A 89 909-18
44. Wood M D et al 2010 Fibrin matrices with affinity-based delivery systems and neurotrophic factors promote functional nerve regeneration Biotechnol. Bioeng. 106 970-9
45. Lee A C et al 2003 Controlled release of nerve growth factor enhances sciatic nerve regeneration Exp. Neurol. 184 295-303 (Pubitemid 37444039)
46. Zern B J, Chu H and Wang Y 2010 Control growth factor release using a self-assembled (polycation:heparin) complex PLoS One 5 e11017
47. Shidhaye S L, Lotlikar V, Malke S and Vilasrao K 2008 Nanogel engineered polymeric micelles for drug delivery Curr. Drug Ther. 3 9
48. Shi L J, Khondee S, Linz T H and Berkland C 2008 Poly(N-vinylformamide) nanogels capable of pH-sensitive protein release Macromolecules 41 6546-54
49. Stanwick J C, Baumann M D and Shoichet M S 2012 Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogel J. Control. Release 160 666-75
50. Wang Y C et al 2008 Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury Biomaterials 29 4546-53
51. Aliabadi H M and Lavasanifar A 2006 Polymeric micelles for drug delivery Expert Opin. Drug Deliv. 3 139-62 (Pubitemid 43056397)
52. Andrieu-Soler C et al 2005 Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1/rd1 mouse Mol. Vis. 11 118-20
53. Aubert-Pouessel A et al 2004 In vitro study of GDNF release from biodegradable PLGA microspheres J. Control. Release 95 463-75 (Pubitemid 38340497)
54. Checa-Casalengua P et al 2011 Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure J. Control. Release 156 92-100
55. de Boer R, Knight A M, Spinner R J, Malessy M J, Yaszemski M J and Windebank A J 2010 In vitro and in vivo release of nerve growth factor from biodegradable poly-lactic-co-glycolic-acid microspheres J. Biomed. Mater. Res. A 95 1067-73
56. Garbayo E, Ansorena E, Lanciego J L, Aymerich M S and Blanco-Prieto M J 2008 Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres Eur. J. Pharm. Biopharm. 69 844-51
57. Garbayo E, Montero-Menei C N, Ansorena E, Lanciego J L, Aymerich M S and Blanco-Prieto M J 2009 Effective GDNF brain delivery using microspheres - a promising strategy for Parkinson's disease J. Control. Release 135 119-26
58. Pean J M, Venier-Julienne M C, Boury F, Menei P, Denizot B and Benoit J P 1998 NGF release from poly(d,l-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability J. Control. Release 56 175-87 (Pubitemid 28511138)
59. Park J H, Ye M L and Park K 2005 Biodegradable polymers for microencapsulation of drugs Molecules 10 146-61 (Pubitemid 40404892)
60. Benoit J P, Faisant N, Venier-Julienne M C and Menei P 2000 Development of microspheres for neurological disorders: from basics to clinical applications J. Control. Release 65 285-96 (Pubitemid 30122933)
61. Xu X Y, Yu H, Gao S J, Mao H Q, Leong K W and Wang S 2002 Polyphosphoester microspheres for sustained release of biologically active nerve growth factor Biomaterials 23 3765-72 (Pubitemid 34632620)
62. Ye M, Kim S and Park K 2010 Issues in long-term protein delivery using biodegradable microparticles J. Control. Release 146 241-60
63. Sinha V R, Bansal K, Kaushik R, Kumria R and Trehan A 2004 Poly-epsilon-caprolactone microspheres and nanospheres: an overview Int. J. Pharm. 278 1-23 (Pubitemid 38670433)
64. Sinha V R and Trehan A 2003 Biodegradable microspheres for protein delivery J. Control. Release 90 261-80 (Pubitemid 36859959)
65. Saralidze K, Koole L H and Knetsch M L W 2010 Polymeric microspheres for medical applications Materials 3 3537-64
66. Shukla S, Brinley E, Cho H J and Seal S 2005 Electrospinning of hydroxypropyl cellulose fibers and their application in synthesis of nano and submicron tin oxide fibers Polymer 46 12130-45 (Pubitemid 41815258)
67. Reneker D H and Chun I 1996 Nanometre diameter fibres of polymer, produced by electrospinning Nanotechnology 7 216-23 (Pubitemid 126558355)
68. Lyons J, Li C and Ko F 2004 Melt-electrospinning: part I. Processing parameters and geometric properties Polymer 45 7597-603 (Pubitemid 39303766)
69. Chew S Y, Wen J, Yim E K F and Leong K W 2005 Sustained release of proteins from electrospun biodegradable fibers Biomacromolecules 6 2017-24 (Pubitemid 41052194)
70. Han D and Cheung K C 2011 Biodegradable cell-seeded nanofiber scaffolds for neural repair Polymers 3 1684-733
71. Maretschek S, Greiner A and Kissel T 2008 Electrospun biodegradable nanofiber nonwovens for controlled release of proteins J. Control. Release 127 180-7
72. Meinel A J, Germershaus O, Luhmann T, Merkle H P and Meinel L 2012 Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications Eur. J. Pharm. Biopharm. 81 1-13
73. Meng Z X et al 2011 Preparation and characterization of electrospun PLGA/gelatin nanofibers as a potential drug delivery system Colloids Surf. B 84 97-102
74. Sill T J and von Recum H A 2008 Electrospinning: applications in drug delivery and tissue engineering Biomaterials 29 1989-2006
75. Venugopal J and Ramakrishna S 2005 Applications of polymer nanofibers in biomedicine and biotechnology Appl. Biochem. Biotechnol. 125 147-57 (Pubitemid 40781145)
76. Jiang H, Hu Y, Li Y, Zhao P, Zhu K and Chen W 2005 A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents J. Control. Release 108 237-43 (Pubitemid 41608657)
77. Jiang X, Cao H Q, Shi L Y, Ng S Y, Stanton L W and Chew S Y 2012 Nanofiber topography and sustained biochemical signaling enhance human mesenchymal stem cell neural commitment Acta Biomater. 8 1290-302
78. Kim T G, Lee D S and Park T G 2007 Controlled protein release from electrospun biodegradable fiber mesh composed of poly(epsilon-caprolactone) and poly(ethylene oxide) Int. J. Pharm. 338 276-83 (Pubitemid 46777227)
79. Liao I C, Chew S Y and Leong K W 2006 Aligned core-shell nanofibers delivering bioactive proteins Nanomedicine 1 465-71
80. Piras A M, Chiellini F, Chiellini E, Nikkola L and Ashammakhi N 2008 New multicomponent bioerodible electrospun nanofibers for dual-controlled drug release J. Bioact. Compat. Polym. 23 423-43
81. Valmikinathan C M, Defroda S and Yu X J 2009 Polycaprolactone and bovine serum albumin based nanofibers for controlled release of nerve growth factor Biomacromolecules 10 1084-9
82. Li W J, Laurencin C T, Caterson E J, Tuan R S and Ko F K 2002 Electrospun nanofibrous structure: a novel scaffold for tissue engineering J. Biomed. Mater. Res. 60 613-21 (Pubitemid 34492600)
83. Aurand E R, Lampe K J and Bjugstad K B 2012 Defining and designing polymers and hydrogels for neural tissue engineering Neurosci. Res. 72 199-213
84. Khademhosseini A and Langer R 2007 Microengineered hydrogels for tissue engineering Biomaterials 28 5087-92 (Pubitemid 47488484)
85. Censi R, Di Martino P, Vemonden T and Hennink W E 2012 Hydrogels for protein delivery in tissue engineering J. Control. Release 161 680-92
86. Burdick J A, Ward M, Liang E, Young M J and Langer R 2006 Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels Biomaterials 27 452-9 (Pubitemid 41457248)
87. Hahn S K, Jelacic S, Maier R V, Stayton P S and Hoffman A S 2004 Anti-inflammatory drug delivery from hyaluronic acid hydrogels J. Biomater. Sci. Polym. Edn 15 1111-9 (Pubitemid 39317376)
88. Koutsopoulos S, Unsworth L D, Nagai Y and Zhang S 2009 Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold Proc. Natl Acad. Sci. USA 106 4623-8
89. Mehrotra S et al 2010 Time controlled protein release from layer-by-layer assembled multilayer functionalized agarose hydrogels Adv. Funct. Mater. 20 247-58
90. Hou S et al 2006 The enhancement of cell adherence and inducement of neurite outgrowth of dorsal root ganglia co-cultured with hyaluronic acid hydrogels modified with Nogo-66 receptor antagonist in vitro Neuroscience 137 519-29 (Pubitemid 43031517)
91. Hou S P et al 2005 The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin J. Neurosci. Methods 148 60-70 (Pubitemid 41423459)
92. Jain A, Kim Y T, McKeon R J and Bellamkonda R V 2006 In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury Biomaterials 27 497-504 (Pubitemid 41457252)
93. Lesny P et al 2002 Polymer hydrogels usable for nervous tissue repair J. Chem. Neuroanat. 23 243-7 (Pubitemid 34606861)
94. Mahoney M J and Anseth K S 2006 Three-dimensional growth and function of neural tissue in degradable polyethylene glycol hydrogels Biomaterials 27 2265-74 (Pubitemid 41774537)
95. Piantino J, Burdick J A, Goldberg D, Langer R and Benowitz L I 2006 An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury Exp. Neurol. 201 359-67 (Pubitemid 44344229)
96. Prang P et al 2006 The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels Biomaterials 27 3560-9
97. Belcheva N, Woodrow-Mumford K, Mahoney M J and Saltzman W M 1999 Synthesis and biological activity of polyethylene glycol-mouse nerve growth factor conjugate Bioconjug. Chem. 10 932-7
98. Goraltchouk A, Scanga V, Morshead C M and Shoichet M S 2006 Incorporation of protein-eluting microspheres into biodegradable nerve guidance channels for controlled release J. Control. Release 110 400-7 (Pubitemid 41827494)
99. Madduri S, Feldman K, Tervoort T, Papaloizos M and Gander B 2010 Collagen nerve conduits releasing the neurotrophic factors GDNF and NGF J. Control. Release 143 168-74
100. Pabari A, Yang S Y, Mosahebi A and Seifalian A M 2011 Recent advances in artificial nerve conduit design: strategies for the delivery of luminal fillers J. Control. Release 156 2-10
101. Yang Y et al 2005 Neurotrophin releasing single and multiple lumen nerve conduits J. Control. Release 104 433-46 (Pubitemid 40724940)
102. Madduri S, Feldman K, Tervoort T, Papaloizos M and Gander B 2010 Collagen nerve conduits releasing the neurotrophic factors GDNF and NGF J. Control. Release 143 168-74
103. Xie J W et al 2009 The differentiation of embryonic stem cells seeded on electrospun nanofibers into neural lineages Biomaterials 30 354-62